RecruitingPhase 2Phase 3NCT06453304

Effectiveness of Glycyrrhizin as Intracanal Medication in Root Canal Disinfection and Inflammatory Cytokines

Clinical Investigation of the Effectiveness of Glycyrrhizin as Intracanal Medication in Root Canal Disinfection and Inflammatory Cytokines


Sponsor

Mansoura University

Enrollment

36 participants

Start Date

Mar 20, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to investigate "clinically" the effectiveness of Glycyrrhizin based intracanal medication compared to the commonly used intracanal medicaments (calcium hydroxide Ca(OH)2 and Ledermix) on the levels of bacteria and inflammatory cytokines in root canals and periradicular tissues of teeth with apical periodontitis.


Eligibility

Min Age: 20 YearsMax Age: 60 Years

Inclusion Criteria1

  • Single-rooted with pulp necrosis and apical periodontitis.

Exclusion Criteria4

  • Receiving antibiotic treatment within the preceding 3 months.
  • Reporting systemic disease.
  • Teeth that could not be isolated with rubber dam.
  • Teeth with periodontal pockets deeper than 3 mm.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCalcium Hydroxide

Intracanal medication

DRUGLeddermix

Intracanal medication

DRUGGlycirrhizin

Intracanal medication


Locations(1)

Alaa Reda Mohamed Eltantawi

Al Mansurah, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06453304


Related Trials